| abstract |
The present invention relates to a pharmaceutical composition for treating ginsenoside F2, a health food, and a feed composition. A pharmaceutical composition comprising ginsenoside F2 suppresses adipogenesis and accumulation in the liver, improves insulin sensitivity, and inflammatory cytokines such as TNF-α, IL-1β, and IL-6 in Kupffer cells Can suppress the expression of endocannabinoid synthase and effectively prevent or treat nonalcoholic liver disease or insulin resistance. [Selection] Figure 6 |